Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.

Challenges in the evaluation and licensing of new pneumococcal vaccines, 7-8 July 2008, Ottawa, Canada.

Feavers I, Knezevic I, Powell M, Griffiths E; WHO Consultation on Serological Criteria for Evaluation and Licensing of New Pneumococcal Vaccines.

Vaccine. 2009 Jun 8;27(28):3681-8. doi: 10.1016/j.vaccine.2009.03.087. Epub 2009 Apr 17.

PMID:
19442421
2.

Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).

Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S97-S108. doi: 10.1097/INF.0b013e318199f61b. Review.

PMID:
19325452
3.

Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.

Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène JP, Lommel P, Dieussaert I, Schuerman L.

Pediatr Infect Dis J. 2009 Apr;28(4 Suppl):S66-76. doi: 10.1097/INF.0b013e318199f8ef.

PMID:
19325449
4.

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members.

Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, O'Brien KL.

Clin Infect Dis. 2008 Oct 15;47(8):989-96. doi: 10.1086/591966.

PMID:
18781875
5.

Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates.

Ongkasuwan J, Valdez TA, Hulten KG, Mason EO Jr, Kaplan SL.

Pediatrics. 2008 Jul;122(1):34-9. doi: 10.1542/peds.2007-2703.

PMID:
18595984
6.

Phase 1 trial of 13-valent pneumococcal conjugate vaccine in Japanese adults.

Scott D, Ruckle J, Dar M, Baker S, Kondoh H, Lockhart S.

Pediatr Int. 2008 Jun;50(3):295-9. doi: 10.1111/j.1442-200X.2008.02593.x.

PMID:
18533940
7.

Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.

Olivier C, Belohradsky BH, Stojanov S, Bonnet E, Petersen G, Liese JG.

Vaccine. 2008 Jun 13;26(25):3142-52. doi: 10.1016/j.vaccine.2007.11.096. Epub 2008 May 6.

PMID:
18502545
8.

Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.

Vestrheim DF, Løvoll O, Aaberge IS, Caugant DA, Høiby EA, Bakke H, Bergsaker MR.

Vaccine. 2008 Jun 19;26(26):3277-81. doi: 10.1016/j.vaccine.2008.03.087. Epub 2008 Apr 18.

PMID:
18456376
9.

Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B.

J Infect Dis. 2008 Apr 1;197(7):1016-27. doi: 10.1086/528996.

PMID:
18419539
10.

Pneumococcal necrotizing pneumonia in Utah: does serotype matter?

Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO, Byington CL.

Clin Infect Dis. 2008 May 1;46(9):1346-52. doi: 10.1086/586747. Erratum in: Clin Infect Dis. 2008 Aug 1;47(3):437.

11.

Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2008 Feb 15;57(6):144-8.

12.

Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004.

Zhou F, Shefer A, Kong Y, Nuorti JP.

Pediatrics. 2008 Feb;121(2):253-60. doi: 10.1542/peds.2007-0619.

PMID:
18245415
13.

Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial.

O'Brien KL, Millar EV, Zell ER, Bronsdon M, Weatherholtz R, Reid R, Becenti J, Kvamme S, Whitney CG, Santosham M.

J Infect Dis. 2007 Oct 15;196(8):1211-20. Epub 2007 Sep 17.

PMID:
17955440
14.

Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.

Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, Reingold A, Farley MM, Whitney CG.

J Infect Dis. 2007 Nov 1;196(9):1346-54. Epub 2007 Oct 4.

PMID:
17922399
15.

Herd immunity and pneumococcal conjugate vaccine: a quantitative model.

Haber M, Barskey A, Baughman W, Barker L, Whitney CG, Shaw KM, Orenstein W, Stephens DS.

Vaccine. 2007 Jul 20;25(29):5390-8. Epub 2007 May 22.

PMID:
17583392
16.

Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.

Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH Jr.

Pediatr Infect Dis J. 2007 Jun;26(6):461-7.

PMID:
17529859
17.

Pneumococcal conjugate vaccine for childhood immunization--WHO position paper.

[No authors listed]

Wkly Epidemiol Rec. 2007 Mar 23;82(12):93-104. English, French. No abstract available.

18.

Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age.

Esposito S, Lizioli A, Lastrico A, Begliatti E, Rognoni A, Tagliabue C, Cesati L, Carreri V, Principi N.

Respir Res. 2007 Feb 21;8:12.

19.

The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease.

Hausdorff WP.

Vaccine. 2007 Mar 22;25(13):2406-12. Epub 2006 Sep 18. Review.

PMID:
17055620
20.

Supplemental Content

Support Center